Literature DB >> 17975118

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.

Dania Mohty1, Philippe Pibarot, Jean-Pierre Després, Claude Côté, Benoit Arsenault, Amélie Cartier, Pierre Cosnay, Christian Couture, Patrick Mathieu.   

Abstract

OBJECTIVE: In patients with severe aortic stenosis (AS), we examine the association between: (1) the content of oxidized LDL (oxLDL) in the aortic valve and the degree of inflammation and remodeling; (2) The proportion of small dense LDL particles in the plasma and the presence of oxLDL in the valve along with hemodynamic progression of valve stenosis. METHODS AND
RESULTS: We have examined 102 explanted AS valves. Tissue remodeling, inflammation, and accumulation of oxLDL were determined. A complete plasma lipid profile including the measurement of the relative proportion of small low-density lipoprotein (%LDL(<255A)) was obtained. Valves with higher oxLDL content had a significantly higher density of inflammatory cells, expression of tumor necrosis factor (TNF)-alpha, and increased tissue remodeling score. The %LDL(<255A) was significantly associated with oxLDL score within the aortic valve. In a subset of 59 patients in whom stenosis progression was measured, the %LDL(<255A) correlated with the annualized peak gradient (r=0.29; P=0.04).
CONCLUSIONS: Increased proportion of circulating small dense LDL particles is associated with faster progression rate of stenosis and greater accumulation of oxLDL in the aortic valve. These findings suggest that therapeutic interventions aimed at lowering the production of small dense LDL particles in patients with AS might represent a potentially interesting therapeutic avenue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975118     DOI: 10.1161/ATVBAHA.107.154989

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  50 in total

Review 1.  The effect of chronic kidney disease on lipid metabolism.

Authors:  Neris Dincer; Tuncay Dagel; Baris Afsar; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

Review 2.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.

Authors:  Kristin Moreth; Renato V Iozzo; Liliana Schaefer
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

3.  Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.

Authors:  Jia Teng Sun; Yuan Yuan Chen; Jing Yan Mao; Yan Ping Wang; Ya Fen Chen; Xiang Hu; Ke Yang; Yan Liu
Journal:  J Cardiovasc Transl Res       Date:  2019-07-31       Impact factor: 4.132

Review 4.  Biomarkers of Calcific Aortic Valve Disease.

Authors:  Aeron Small; Daniel Kiss; Jay Giri; Saif Anwaruddin; Hasan Siddiqi; Marie Guerraty; Julio A Chirinos; Giovanni Ferrari; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

5.  RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

Authors:  Sandra Guauque-Olarte; Arnaud Droit; Joël Tremblay-Marchand; Nathalie Gaudreault; Dimitri Kalavrouziotis; Francois Dagenais; Jonathan G Seidman; Simon C Body; Philippe Pibarot; Patrick Mathieu; Yohan Bossé
Journal:  Physiol Genomics       Date:  2016-08-05       Impact factor: 3.107

Review 6.  Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.

Authors:  Nimesh Patel; Dharam J Kumbhani
Journal:  Curr Heart Fail Rep       Date:  2018-10

7.  Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.

Authors:  Habib Derbali; Yohan Bossé; Nancy Côté; Philippe Pibarot; Audrey Audet; Andree Pépin; Benoit Arsenault; Christian Couture; Jean-Pierre Després; Patrick Mathieu
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 8.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

9.  Inflammation is associated with the remodeling of calcific aortic valve disease.

Authors:  Nancy Coté; Ablajan Mahmut; Yohan Bosse; Christian Couture; Sylvain Pagé; Sylvain Trahan; Marie-Chloé Boulanger; Dominique Fournier; Philippe Pibarot; Patrick Mathieu
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 10.  Abdominal obesity and the metabolic syndrome: a surgeon's perspective.

Authors:  Patrick Mathieu
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.